Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BETA CAROTENE, LUTEIN/ZEAXANTHIN INTAKE LINKED TO LOWER RISK OF EYE DISEASE

This article was originally published in The Tan Sheet

Executive Summary

BETA CAROTENE, LUTEIN/ZEAXANTHIN INTAKE LINKED TO LOWER RISK OF EYE DISEASE in a case-control study evaluating the relationship between dietary intake of antioxidant vitamins and the risk of neovascular age-related macular degeneration that appears in the Nov. 9 issue of the Journal of the American Medical Association. The authors, Johanna Seddon, MD, Harvard School of Public Health, et al., concluded that "beta carotene and lutein/zeaxanthin were associated with a statistically significant trend for reduction in risk for AMD with higher intake, with an odds ratio of .59 for beta carotene and .43 for lutein/zeaxanthin, comparing the highest to the lowest quintile of intake for each."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083417

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel